* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Euro-Med Laboratories Philippines Days Payable Chart
PHS:EURO vs ZTS, UTHR, VTRS: Days Payable Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Euro-Med Laboratories Philippines's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Euro-Med Laboratories Philippines Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Euro-Med Laboratories Philippines's Days Payable distribution charts can be found below:
* The bar in red indicates where Euro-Med Laboratories Philippines's Days Payable falls into.
Euro-Med Laboratories Philippines Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Euro-Med Laboratories Philippines (PHS:EURO) has a Days Payable of 29.57 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Euro-Med Laboratories Philippines and its competitors. This is 34% below median its historical median of 45.01. Over the past decade, Euro-Med Laboratories Philippines' Days Payable has ranged from 27.60 to 83.64. According to the industry distribution chart, Euro-Med Laboratories Philippines ranks #842 out of 922 companies in the Drug Manufacturers industry, placing it in the top 91.3%.
Is Euro-Med Laboratories Philippines' Days Payable too high?
Euro-Med Laboratories Philippines' current Days Payable of 29.57 is 34% below median its 10-year median of 45.01. Over the past 10 years, this metric has ranged from a low of 27.60 to a high of 83.64. The Drug Manufacturers industry median Days Payable is 90.84. Euro-Med Laboratories Philippines' value of 29.57 is 67.4% below this industry median. Based on the distribution chart, Euro-Med Laboratories Philippines ranks #842 out of 922 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Euro-Med Laboratories Philippines has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Euro-Med Laboratories Philippines' Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Euro-Med Laboratories Philippines ranks #842 out of 922 companies for Days Payable. This places Euro-Med Laboratories Philippines in the lower half of its industry. The industry median Days Payable is 90.84. Euro-Med Laboratories Philippines' value of 29.57 is 67.4% below this benchmark. Historically, Euro-Med Laboratories Philippines' own Days Payable has ranged from 27.60 to 83.64 over the past decade. While the company's 10-year median is 45.01 vs. the industry median of 90.84, Euro-Med Laboratories Philippines has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.84, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Euro-Med Laboratories Philippines's current Days Payable of 29.57 is 67.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Euro-Med Laboratories Philippines and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Euro-Med Laboratories Philippines's current Days Payable is 29.57, which is 34% below median its own 10-year median of 45.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Euro-Med Laboratories Philippines stock overvalued right now?
Based on GuruFocus' analysis, Euro-Med Laboratories Philippines (PHS:EURO) is currently considered Fairly Valued. The stock's GF Value™ is ₱1.02, compared to a current price of ₱1.10 — trading 7.8% above its estimated fair value. The current Days Payable is 29.57, which is 34% below median its 10-year median of 45.01 and 67.4% below the Drug Manufacturers industry median of 90.84. Euro-Med Laboratories Philippines' overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Euro-Med Laboratories Philippines (PHS:EURO), the current Days Payable is 29.57 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Euro-Med Laboratories Philippines (PHS:EURO) Overvalued in 2026?
Based on GuruFocus' analysis, Euro-Med Laboratories Philippines stock appears to be overvalued.
The current stock price of ₱1.10 is trading 7.8% above its estimated GF Value™ of ₱1.02.
GuruFocus considers Euro-Med Laboratories Philippines to be Fairly Valued.
Key valuation signals for PHS:EURO:
Days Payable: 29.57 (34% below median its 10-year median of 45.01)
GF Value™: ₱1.02 vs. price of ₱1.10 (7.8% above fair value)
Industry Position: 67.4% below the Drug Manufacturers median (#842 of 922)
No single metric tells the full story. See the PHS:EURO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Euro-Med Laboratories Philippines Business Description
Euro-Med Laboratories Philippines Inc is a pharmaceutical-based company that engages in the manufacture of pharmaceutical products such as large and small-volume parenterals and other solutions. The company also manufactures sterile water for injection, and other solutions such as ophthalmic, inhalation, irrigation, and dialysis. The Company also manufactures intravenous fluids in glass bottles, hemodialysis concentrates, ophthalmic products and disinfectants.
82GF Score
Get the complete analysis for PHS:EURO
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PHS:EURO has been successfully added to your 
